Literature DB >> 11556684

Paraproteinemic neuropathies.

A Vital1.   

Abstract

The occurrence of a peripheral neuropathy (PN) in association with a monoclonal gammopathy is quite common and suggests that monoclonal proteins may play a pathogenetic role in peripheral nervous system damage. In fact, paraproteinemic PN constitute an heterogeneous group of disorders related to various pathogenetic factors, and the histopathologic features in peripheral nerve biopsies differ from one condition to another. In several well defined disorders, the responsibility of the monoclonal component in the development of the PN has been evidenced. This is the case for most of the PN associated with an IgM monoclonal gammopathy, either a monoclonal gammopathy of undetermined significance (MGUS) or Waldenstrom's macroglobulinemia. The responsibility of the monoclonal protein in the occurrence of amyloid neuropathy related to multiple myeloma is also recognized. However, most IgG or IgA MGUS, as well as the monoclonal component in POEMS syndrome, have an uncertain causal relationship with the neuropathy. PN associated with monoclonal cryoglobulin (type 1) are occasional and differ from those associated with mixed cryoglobulins (types 2 or 3).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556684     DOI: 10.1111/j.1750-3639.2001.tb00407.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  10 in total

1.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 2.  [Autoimmune neuropathies--current aspects of immunopathologic diagnostics and therapy].

Authors:  R Gold; A Bayas; K V Toyka
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  Peripheral neuropathies in Waldenström's macroglobulinaemia.

Authors:  T Levine; A Pestronk; J Florence; M T Al-Lozi; G Lopate; T Miller; I Ramneantu; W Waheed; M Stambuk; M J Stone; R Choksi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 4.  An update on monoclonal gammopathy and neuropathy.

Authors:  Sindhu Ramchandren; Richard A Lewis
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 5.  Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

6.  [Leptomeningeal tumor cell infiltrations as a first manifestation of an immunocytoma (Waldenstrom's macroglobulinemia)].

Authors:  A Hug; J Haas; B Storch-Hagenlocher; B Wildemann
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

7.  Clinical Neuropathology practice guide 3-2014: combined nerve and muscle biopsy in the diagnostic workup of neuropathy - the Bordeaux experience.

Authors:  Anne Vital; Claude Vital
Journal:  Clin Neuropathol       Date:  2014 May-Jun       Impact factor: 1.368

8.  Neuropathy associated with immunoglobulin M monoclonal gammopathy: A combined sonographic and nerve conduction study.

Authors:  H Stephan Goedee; Nicolette C Notermans; Leo H Visser; Jan-Thies H van Asseldonk; Hessel Franssen; Alexander F J E Vrancken; Stavros Nikolakopoulos; Leonard H van den Berg; W Ludo van der Pol
Journal:  Muscle Nerve       Date:  2019-07-24       Impact factor: 3.217

9.  Atypical B12 deficiency with nonresolving paraesthesia.

Authors:  S Haider; N Ahmad; E J Anaissie; N Abdel Karim
Journal:  Case Rep Oncol Med       Date:  2013-11-18

Review 10.  Paraproteinemic neuropathy: a practical review.

Authors:  Richard A Rison; Said R Beydoun
Journal:  BMC Neurol       Date:  2016-01-28       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.